STOCK TITAN

Ginkgo Executive's Steady Stock Sales Continue as Share Price Climbs 50%

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 filing for Ginkgo Bioworks Holdings details proposed sale of securities by insider Austin Che. Key details:

  • Proposed sale of 99 Class A shares through Fidelity Brokerage Services, with aggregate market value of $857.34
  • Shares were acquired on October 12, 2022 through restricted stock vesting as compensation
  • Extensive trading history shows consistent sales of 99 shares per transaction from March-June 2025
  • Sale prices have ranged from $5.16 to $9.51 per share over the past 3 months
  • Total shares outstanding: 46,344,630

The planned sale represents a continuation of a systematic selling pattern, with the insider executing regular small-volume transactions. Recent trading shows increasing share prices, with June 2025 transactions averaging higher values than earlier months.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many DNA shares is Austin Che planning to sell according to the Form 144 filing from June 2025?

According to the Form 144 filing, Austin Che plans to sell 99 shares of DNA Class A common stock with an aggregate market value of $857.34. The approximate date of sale is listed as 06/20/2025 on the NYSE.

What is the trading pattern of DNA shares sold by Austin Che in the past 3 months before June 2025?

Austin Che has consistently sold 99 shares of DNA Class A stock each trading day over the past 3 months. The sale prices have fluctuated, with recent transactions ranging from lows around $510.84 (04/07/2025) to highs of $941.49 (06/12/2025) in gross proceeds per daily transaction.

How did Austin Che originally acquire the DNA shares being sold?

Austin Che acquired the DNA shares through Restricted Stock Vesting on 10/12/2022 as part of compensation from the issuer (Ginkgo Bioworks Holdings, Inc.). The amount of securities acquired at that time was 99 shares of Class A stock.

What is the total number of DNA shares outstanding according to the June 2025 Form 144?

According to the Form 144 filing, the total number of DNA shares (Class A) outstanding is 46,344,630 units.

Which brokerage is handling the DNA share sale for Austin Che?

Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield RI 02917, is handling the sale of DNA shares for Austin Che.
Ginkgo Bioworks Holdings Inc

NYSE:DNA

DNA Rankings

DNA Latest News

DNA Latest SEC Filings

DNA Stock Data

536.83M
58.30M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
BOSTON